AbCellera Biologics Inc Live Stock Price Today, Share Analysis and Chart

Name: AbCellera Biologics Inc: Is Infosys Ltd. worth buying?
Item: AbCellera Biologics Inc
Rating: 1.264333375
Author: Trendlyne DVM scores

Momentum Trap

about

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that ...

4.40 -0.37 (-7.76%)

32.52% Fall from 52W High

7.3M

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Low Financial Strength

16.7 / 100

Expensive Valuation

17.3 / 100

Technically Neutral

50.5 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 130%

7 analysts

AbCellera Biologics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

AbCellera Biologics Inc Live Stock Price Today, Share Analysis and Chart

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that ...

32.52% Fall from 52W High

SWOT Analysis

AbCellera Biologics Inc Live Price Chart